Didier Martin, Head of Pharma at Sanofi-Aventis Vietnam, highlighted the value of strategic alliances in healthcare innovation. "At Sanofi, we believe collaboration is crucial for driving innovation ...

Sanofi-Aventis stock holds position with TD Cowen citing advancements in anti-TL1A therapies Editor Ahmed Abdulazez Abdulkadir Analyst Ratings Published 12/18/2024, 09:56 AM ...

Sanofi-Aventis Deutschlan GMBH v. Mylan Pharmaceuticals Inc. by: Sofya Asatryan of Sheppard, Mullin, Richter & Hampton LLP - Intellectual Property Law Blog Thursday, August 3, 2023 ...

Sanofi-Aventis SA reported Friday a 6 percent rise in third-quarter profit and said strong sales of its vaccine against swine flu will drive earnings higher than expected for the full year.

In a report released on January 26, Graham Parry from Bank of America Securities maintained a Buy rating on Sanofi-Aventis Sa (SNY – Research Report), with a price target of $65.00. The company ...

(RTTNews) - The U.S. Food and Drug Administration has accepted for priority review the Biologics License Application (BLA) for efanesoctocog alfa (BIVV001) for the treatment of hemophilia A, a ...

Sanofi and Sobi collaborate on the development and commercialization of efanesoctocog alfa. For More Such Health News, visit rttnews.com ...

Sanofi has unveiled its new corporate brand image, which reflects the organisation’s ongoing transformation and modernisation. Sanofi has been involved in patient-centric scientific discovery for 50 ...

Pharma giant Sanofi continues to modernise with branding which reflects its commitment to social responsibility and sustainability Sanofi has revealed a new corporate brand which supports the ...

Sanofi's changes aren’t stopping with the logo, either: More than a decade after buying out Genzyme, the U.S. biotech, it will now move the Sanofi Genzyme unit under the Sanofi branding.